NASDAQ:UTRS Minerva Surgical Q2 2023 Earnings Results & Report $0.0001 0.00 (0.00%) As of 11/9/2026 01:25 PM Eastern Minerva Surgical beat analyst earnings expectations but missed on revenue in its Q2 2023 results, released August 2, 2023. The company reported EPS of -$1.00 versus the -$1.80 consensus estimate, while revenue of $13.39 million fell short of the $13.92 million estimate by $530.00 thousand. Research:Profile Earnings Announcement Details QuarterQ2 2023Report DateAugust 2, 2023 Minerva Surgical EPS ResultsActual EPS-$1.00Consensus EPS -$1.80Beat/MissBeat by +$0.80One Year Ago EPSN/AEPS Beat Rate3 of last 7 quartersMinerva Surgical Revenue ResultsActual Revenue$13.39 millionExpected Revenue$13.92 millionBeat/MissMissed by -$530.00 thousandYoY Revenue GrowthN/AUpcoming EarningsMinerva Surgical's next earnings date is estimated for Tuesday, November 17, 2026, based on past reporting schedules. Conference Call ResourcesCompany Profile Minerva Surgical Q2 2023 Earnings FAQ Did Minerva Surgical beat earnings estimates for Q2 2023? Minerva Surgical (NASDAQ:UTRS) reported earnings of -$1.00 per share for Q2 2023, beating the consensus estimate of -$1.80. The report was announced on Wednesday, August 2, 2023. What was Minerva Surgical's revenue for Q2 2023? Minerva Surgical reported revenue of $13.39 million for Q2 2023, against a consensus estimate of $13.92 million. When is Minerva Surgical's next earnings date? Minerva Surgical's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for Minerva Surgical on the company's earnings history page. Minerva Surgical Earnings HeadlinesMinerva Surgical Inc.January 10, 2024 | thestreet.comWhy Is Minerva Surgical (UTRS) Stock Down 50% Today?December 18, 2023 | markets.businessinsider.comMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a household name. Now he says a similar shift is unfolding in AI infrastructure. Hundreds of billions are pouring into AI data centers, but he warns the builders could get crushed by their own costs while one overlooked sector absorbs the spending.November 10 at 1:00 AM | Porter & Company (Ad)Minerva Surgical Inc UTRSDecember 17, 2023 | morningstar.comMMinerva Surgical, Inc.: Minerva Surgical Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | finanznachrichten.deMinerva Surgical GAAP EPS of -$0.81 misses by $0.27, revenue of $12M misses by $1.93MNovember 14, 2023 | msn.comSee More Minerva Surgical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Minerva Surgical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Minerva Surgical and other key companies, straight to your email. Email Address About Minerva SurgicalMinerva Surgical (NASDAQ:UTRS) is a medical device company focused on women’s health. The company develops and commercializes technologies intended to diagnose and treat conditions affecting the uterus, with an emphasis on abnormal uterine bleeding, a common condition that can significantly affect quality of life. Its product portfolio includes the Minerva ES Endometrial Ablation System, which uses controlled energy to treat heavy menstrual bleeding, and the Symphion System, a hysteroscopic tissue-removal device used in procedures involving uterine fibroids and polyps. The company has also offered the Genesys HTA System, an endometrial ablation technology designed for use in treating abnormal uterine bleeding. Minerva Surgical sells its products primarily through healthcare providers, hospitals, and surgical facilities, serving the U.S. market and select international markets. The company was founded in 2008 and is headquartered in Redwood City, California. Its business has historically centered on providing less-invasive alternatives to more extensive surgical procedures in gynecology.View Minerva Surgical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles D-Wave Quantum Has Long-Term Potential, But Is Now the Time to Buy?Archer Aviation's FAA Certificate Is a Milestone, But It Isn't the Final OneDraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Microsoft’s Neocloud Pullback Isn’t a Crack in AI DemandOklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next? Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
